SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

CORRESP Filing

Minerva Neurosciences, Inc.
Date: March 17, 2026 · CIK: 0001598646 · Accession: 0001193125-26-109862

Offering / Registration Process

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

File numbers found in text: 333-294203

Date
March 17, 2026
Author
Remy Luthringer
Form
CORRESP
Company
Minerva Neurosciences, Inc.

Letter

Re:

March 17, 2026 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance Office of Life Sciences 100 F Street, N.E. Washington, D.C. 20549 Attn: Lauren S. Hamill

Minerva Neurosciences, Inc.

Registration Statement on Form S-3

File No. 333-294203 Acceleration Request Requested Date: March 19, 2026 Requested Time: 4:00 PM Eastern Time Ladies and Gentlemen: In accordance with Rule 461 under the Securities Act of 1933, as amended, the undersigned registrant (the “ Registrant ”) hereby requests that the Securities and Exchange Commission (the “ Commission ”) take appropriate action to cause the Registration Statement on Form S-3 (File No.: 333-294203) (the “ Registration Statement ”) to become effective on Thursday, March 19, 2026 at 4:00 p.m. Eastern Time, or as soon as practicable thereafter, or at such later time as the Registrant may orally request via telephone call to the staff of the Commission. The Registrant hereby authorizes Ryan S. Sansom of Cooley LLP, counsel to the Registrant, to make such request on its behalf. Once the Registration Statement has been declared effective, please orally confirm that event with Ryan S. Sansom of Cooley LLP, counsel to the Registrant, at (617) 937-2335.

Very truly yours,
Minerva Neurosciences, Inc.

Show Raw Text
CORRESP
 1
 filename1.htm

 CORRESP

 March 17, 2026
 VIA EDGAR U.S. Securities and Exchange Commission
 Division of Corporation Finance Office of Life Sciences
 100 F Street, N.E. Washington, D.C. 20549
 Attn: Lauren S. Hamill

 Re:

 Minerva Neurosciences, Inc.

 Registration Statement on Form S-3

 File No. 333-294203
 Acceleration Request
 Requested Date:  March 19, 2026
 Requested Time: 4:00 PM Eastern Time
 Ladies and Gentlemen: In accordance with Rule
461 under the Securities Act of 1933, as amended, the undersigned registrant (the “ Registrant ”) hereby requests that the Securities and Exchange Commission (the “ Commission ”) take appropriate
action to cause the Registration Statement on Form S-3 (File No.: 333-294203) (the “ Registration Statement ”) to become
effective on Thursday, March 19, 2026 at 4:00 p.m. Eastern Time, or as soon as practicable thereafter, or at such later time as the Registrant may orally request via telephone call to the staff of the Commission. The Registrant hereby
authorizes Ryan S. Sansom of Cooley LLP, counsel to the Registrant, to make such request on its behalf. Once the Registration Statement
has been declared effective, please orally confirm that event with Ryan S. Sansom of Cooley LLP, counsel to the Registrant, at (617) 937-2335.

 Very truly yours,

 Minerva Neurosciences, Inc.

 By:

 /s/ Remy Luthringer

 Remy Luthringer

 Chief Executive Officer

 cc:
 Remy Luthringer, Chief Executive Officer, Minerva Neurosciences, Inc.
 Frederick Ahlholm, Chief Financial Officer, Minerva Neurosciences, Inc.
 Marc Recht, Cooley LLP Ryan S.
Sansom, Cooley LLP